Inactive Instrument

Highlights United Gene High-Tech Group Ltd Hong Kong S.E.

Equities

0399

KYG9235H1294

Highlights

Unlock all the news: Be the first to know and act before the market!

Innovative Pharmaceutical Renews THU Agreement, Revises Product's Commercialization Timeline	06-26	MT
Innovative Pharmaceutical Biotech Limited Provides Update on the Status of the Commercialization of the Oral Insulin Product (The "Product") and the Latest Business Development of the Group	06-25	CI
Innovative Pharmaceutical Biotech Returns to Fiscal H1 Attributable Profit	11-30	MT
Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Half Year Ended September 30, 2023	11-29	CI
Innovative Pharmaceutical Biotech to Return to Profit in Fiscal H1	11-28	MT
Innovative Pharmaceutical Biotech Limited Provides Unaudited Earnings Guidance for the Six Months Ended 30 September 2023	11-27	CI
Innovative Pharmaceutical Eyes Majority Stake in US Neurotechnology Firm	05/09/23	MT
Innovative Pharmaceutical Biotech Limited entered into a memorandum of understanding to acquire a majority interest in Niraxx Light Therapeutics, Inc.	03/09/23	CI
Innovative Pharmaceutical Biotech Incurs Loss in Fiscal Year 2023	30/06/23	MT
Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023	29/06/23	CI
Innovative Pharmaceutical Biotech Mulls Over Capital Injection in Technical Services Company	20/01/23	MT
Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Half Year Ended September 30, 2022	29/11/22	CI
Innovative Pharmaceutical Biotech Forecasts Swing to Loss in April-September Period	25/11/22	MT
Innovative Pharmaceutical Biotech Limited Provides Group Earnings Guidance for the Six Months Ending 30 September 2022	24/11/22	CI
Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2022	29/06/22	CI
Innovative Pharmaceutical Biotech Swings to Profit on Noncash Item Credit in Fiscal H1	30/11/21	MT
Innovative Pharmaceutical Biotech Limited Reports Earnings Results for the Half Year Ended September 30, 2021	29/11/21	CI
Innovative Pharmaceutical to Swing to Fiscal H1 Profit	26/11/21	MT
Innovative Pharmaceutical Biotech Limited Provides Earnings Guidance for the Six Months Ending September 30, 2021	25/11/21	CI
Singapore's Temasek portfolio surges to record after market rally	13/07/21	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights United Gene High-Tech Group Ltd Hong Kong S.E.

Equities

0399

KYG9235H1294

Highlights

Filters